Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Imclone systems (IMCL) -- Ignore unavailable to you. Want to Upgrade?

To: CPAMarty who wrote (323)	2/26/1999 2:17:00 PM
From: 5,17,37,5,101,...	Read Replies (2) \| Respond to of 2515

Well, well. All this talk about things we really already know, but no mention of C225 entering PIII trials. The last time one of my stocks was mentioned on CNBC was when M. Murphy recommended IDTI at $12. HA! Boy did he jinx that one! I see lots of volume here. Lots of message. No news. and the stock is unchanged. Yesterdays pop at the end of the day seemed a bit suspicious. Today's pop to $11 does also. Lots of people are selling a lot whenever the market can bear it. WHO? 1) Daytraders taking profits at what they consider to be prices at the high end of the range without news; and who will be stuck with minimal positions on any sustained appreciation; or 2) Institutional investors who see something we don't, either something specific to the company or the economy. Well, $10.50 is hardly the high end of the range considering IMCL has been to $13 7/8. So I begin to rule out case 1. I begin to think more about case 2 when I see large volumes with little price change. The last time this ocurred in December there was a serious intraday reversal on heavy volume followed by a rather disturbing decline. May lighten up in the next few days. Jackson